HEALTHCARE
Clinical Trial Eligibility
DIAGNOSIS
NSCLC Stage IIIB
PROTOCOL
Pembrolizumab + Chemo
CRITERIA REVIEW
·
NSCLC diagnosis confirmed
inclusion
·
ECOG performance status 0–2
inclusion
·
Prior platinum-based therapy
inclusion
·
No active CNS metastases
exclusion
·
No prior immunotherapy
exclusion
·
Adequate renal function (eGFR ≥ 45)
inclusion
← Templatesnodus:approval-cardnodus:reasoning-treenodus:provenance-chainnodus:agent-timeline